Bria-IMT + Retifanlimab vs Physician's Choice in Advanced Metastatic Breast Cancer

Market
100%75%50%25%0%Apr 26 • YES 24.0%Apr 26
Trade

Will this trial meet its primary endpoint?

Paper Trading
Create account to trade
DetailsModel PositionsModel SnapshotsOracle
No oracle findings have been stored for this trial yet.
Stats
Latest Run
No runs yet
Model
No runs yet
Runs
0 runs